Abstract | OBJECTIVES: METHODS: From October 1981 to May 1999, 68 (62%) of 109 patients with distant metastases were recruited. Thirty-six (53%) received salvage treatment at the time of significant increase in one or more components of CEA-TPA-CA15.3 tumour marker panel and negative instrumental examinations ("tumour marker guided" treatment) and 32 (47%) were treated only after radiological confirmation of metastases (conventional treatment). The prognostic factors of the two groups did not show any statistically significant difference. RESULTS: The time from one or more tumour marker increase to clear clinical and/or radiological signs of distant metastases (lead time) was significantly prolonged in the 36 patients with "tumour marker guided" treatment (17.3 +/- 13.1 vs. 2.9 +/- 2.9 months, P < 0.001, Wilcoxon test) as well as the survival curves from salvage therapy and from mastectomy (the proportion of survivors was: at 36 months from salvage therapy 28% vs. 9%, P = 0.0094; at 84 months from mastectomy 42% vs. 19%, P = 0.0017). The multivariate Cox analysis showed that time from mastectomy to tumour marker increase and "tumour marker guided" salvage treatment were the only significantly different variables (P = 0.00001 and 0.005, respectively). CONCLUSION: These data point out that "tumour marker guided" salvage treatment significantly prolongs disease-free and overall survivals of relapsing responsive patients.
|
Authors | Andrea Nicolini, Angelo Carpi, Claudio Michelassi, Claudio Spinelli, Massimo Conte, Paolo Miccoli, M Fini, R Giardino |
Journal | Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
(Biomed Pharmacother)
Vol. 57
Issue 10
Pg. 452-9
(Dec 2003)
ISSN: 0753-3322 [Print] France |
PMID | 14637388
(Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Biomarkers, Tumor
- Carcinoembryonic Antigen
- Mucin-1
- Peptides
- tissue polypeptide specific antigen
|
Topics |
- Biomarkers, Tumor
(blood)
- Breast Neoplasms
(mortality, pathology, therapy)
- Carcinoembryonic Antigen
(blood)
- Female
- Humans
- Middle Aged
- Mucin-1
(blood)
- Neoplasm Metastasis
- Peptides
(blood)
- Salvage Therapy
(mortality)
|